The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-β

Department of Biochemistry and Cell Biology, School of Medicine, WCU Program, Cell and Matrix Research Institute, Kyungpook National University, Daegu 700-422, South Korea.
Journal of Cellular Biochemistry (Impact Factor: 3.26). 05/2010; 110(1):97-103. DOI: 10.1002/jcb.22516
Source: PubMed


Cleidocranial dysplasia (CCD) is caused by haploinsufficiency in RUNX2 function. We have previously identified a series of RUNX2 mutations in Korean CCD patients, including a novel R131G missense mutation in the Runt-homology domain. Here, we examine the functional consequences of the RUNX2(R131G) mutation, which could potentially affect DNA binding, nuclear localization signal, and/or heterodimerization with core-binding factor-beta (CBF-beta). Immunofluorescence microscopy and western blot analysis with subcellular fractions show that RUNX2(R131G) is localized in the nucleus. Immunoprecipitation analysis reveals that heterodimerization with CBF-beta is retained. However, precipitation assays with biotinylated oligonucleotides and reporter gene assays with RUNX2 responsive promoters together reveal that DNA-binding activity and consequently the transactivation of potential of RUNX2(R131G) is abrogated. We conclude that loss of DNA binding, but not nuclear localization or CBF-beta heterodimerization, causes RUNX2 haploinsufficiency in patients with the RUNX2(R131G) mutation. Retention of specific functions including nuclear localization and binding to CBF-beta of the RUNX2(R131G) mutation may render the mutant protein an effective competitor that interferes with wild-type function.

Download full-text


Available from: Suk-Chul Bae, Mar 11, 2014
  • Source
    • "It was previously shown that Cbfβ interacts with Runx2 in bone and cartilage and enhances Runx2-mediated transcription (Kundu et al, 2002; Yoshida et al, 2002; Nakashima and Crombrugghe, 2003; Kanatani et al, 2006; Han et al, 2010). Higashikawa et al (2009) showed that human COL10A1 promoter activity, which was enhanced by RUNX2, was further potentiated by RUNX2 in combination with the coactivator CBFβ. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The CBFb gene encodes a transcription factor that, in combination with CBFa (also called Runx, runt- related transcription factor) regulates expression of several target genes. CBFb interacts with all Runx family members, such as RUNX2, a regulator of bone-related gene transcription that contains a conserved DNA-binding domain. CBFb stimulates DNA binding of the Runt domain, and is essential for most of the known functions of RUNX2. A comparative analysis of the zebrafish cbfb gene and protein, and of its orthologous identified homologous proteins in different species indicates a highly conserved function.We cloned eleven zebrafish cbfb gene transcripts, one resulting in the known Cbfb protein (with 187 aa), and three additional variants resulting from skipping exon 5a (resulting in a protein with 174 aa) or exon 5b (resulting in a protein with 201 aa), both observed for the first time in zebrafish, and a completely novel isoform containing both exon 5a and 5b (resulting in a protein with 188 aa). Functional analysis of these isoforms provides insight into their role in regulating gene transcription. From the other variants two are premature termination Cbfb forms, while the others show in-frame exon-skipping causing changes in the Cbfb domain that may affect its function.
    Archives of Biochemistry and Biophysics 01/2015; 567. DOI:10.1016/ · 3.02 Impact Factor
  • Source
    • "After 4~6 hours of transfection, cells were cultured in the presence or absence of 10-7 mol/l 1,25(OH)2D3 for 24 hours and NEs were prepared using the NE-PER kit. Co-immunoprecipitation analysis was performed as previously described [38]. To remove non-specific binding proteins, protein G Sepharose (Santa Cruz) slurry was added to 130 μg aliquots of NEs and incubated at 4°C for 2 hours with rotation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification. We investigated the roles of vitamin D receptor (Vdr) and runt-related transcription factor 2 (Runx2) in the osteoblastic differentiation of VSMCs in response to vitamin D3 using in vitro VSMCs cultures and in vivo in Vdr knockout (Vdr (-/-) ) and Runx2 carboxy-terminus truncated heterozygous (Runx2 (+/ΔC) ) mice. Treatment of VSMCs with active vitamin D3 promoted matrix mineral deposition, and increased the expressions of Vdr, Runx2, and of osteoblastic genes but decreased the expression of smooth muscle myosin heavy chain in primary VSMCs cultures. Immunoprecipitation experiments suggested an interaction between Vdr and Runx2. Furthermore, silencing Vdr or Runx2 attenuated the procalcific effects of vitamin D3. Functional cooperation between Vdr and Runx2 in vascular calcification was also confirmed in in vivo mouse models. Vascular calcification induced by high-dose vitamin D3 was completely inhibited in Vdr (-/-) or Runx2 (+/ΔC) mice, despite elevated levels of serum calcium or alkaline phosphatase. Collectively, these findings suggest that functional cooperation between Vdr and Runx2 is necessary for vascular calcification in response to vitamin D3.
    PLoS ONE 12/2013; 8(12):e83584. DOI:10.1371/journal.pone.0083584 · 3.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Two key molecules in skeletal tissues are bone formation master transcription factor Runx2 and the steroid hormone estrogen. It is well known that these two molecules play pivotal roles in bone homeostasis; however, the functional interaction between Runx2 and estrogen synthesis in skeletal tissues is largely unknown. Recent studies have indicated that there is a positive relationship between Runx2 and the estrogen biosynthesis pathway. In this review, a possible functional link between Runx2 and estrogen synthesis pathway in skeletal tissues will be discusses as well as the biological significance of this interaction.
    BMB reports 10/2011; 44(10):613-8. DOI:10.5483/BMBRep.2011.44.10.613 · 2.60 Impact Factor
Show more